Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Leucovorin Calcium, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
by on Tuesday, August 7th, 2012 | No Comments
Condition: Pancreatic Cancer
Interventions: Drug: Akt inhibitor MK2206; Drug: FOLFOX regimen; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Drug: selumetinib
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Not yet recruiting – verified August 2012
Originally posted here: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Leucovorin Calcium, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy